1-20 of 21
Robert L Vessella
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse Models

Mari I. Suominen, Katja M. Fagerlund, Jukka P. Rissanen, Yvonne M. Konkol, Jukka P. Morko, ZhiQi Peng, Esa J. Alhoniemi, Salla K. Laine, Eva Corey, Dominik Mumberg, Karl Ziegelbauer, Sanna-Maria Käkönen, Jussi M. Halleen, Robert L. Vessella, Arne Scholz
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (15): 4335–4346.
https://doi.org/10.1158/1078-0432.CCR-16-2955
Published: 01 August 2017
View article titled, Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse Models
Open the PDF for Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse Models in another window
Includes: Supplementary data
Journal Articles

Characterization of an Abiraterone Ultraresponsive Phenotype in Castration-Resistant Prostate Cancer Patient-Derived Xenografts

Hung-Ming Lam, Ryan McMullin, Holly M. Nguyen, Ilsa Coleman, Michael Gormley, Roman Gulati, Lisha G. Brown, Sarah K. Holt, Weimin Li, Deborah S. Ricci, Karin Verstraeten, Shibu Thomas, Elahe A. Mostaghel, Peter S. Nelson, Robert L. Vessella, Eva Corey
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (9): 2301–2312.
https://doi.org/10.1158/1078-0432.CCR-16-2054
Published: 30 April 2017
View article titled, Characterization of an Abiraterone Ultraresponsive Phenotype in Castration-Resistant Prostate Cancer Patient-Derived Xenografts
Open the PDF for Characterization of an Abiraterone Ultraresponsive Phenotype in Castration-Resistant Prostate Cancer Patient-Derived Xenografts in another window
Includes: Supplementary data
Journal Articles

GRM1 is An Androgen-Regulated Gene and its Expression Correlates with Prostate Cancer Progression in Pre-Clinical Models

Mojgan Shourideh, Gissou Azabdaftari, Kristopher Attwood, Adam DePriest, Kristine M Wadosky, Bryan M Gillard, Ellen Karasik, Hannelore Heemers, Natasha Kyprianou, Irwin H. Gelman, Eva Corey, Robert L Vessella, James L. Mohler, Shahriar Koochekpour
Journal: Clinical Cancer Research
Clin Cancer Res clincanres.0137.2016.
https://doi.org/10.1158/1078-0432.CCR-16-0137
Published: 25 July 2016
View article titled, GRM1 is An Androgen-Regulated Gene and its Expression Correlates with Prostate Cancer Progression in Pre-Clinical Models
Open the PDF for GRM1 is An Androgen-Regulated Gene and its Expression Correlates with Prostate Cancer Progression in Pre-Clinical Models in another window
Includes: Supplementary data
Journal Articles

Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas

Harrison Tsai, Carlos L. Morais, Mohammed Alshalalfa, Hsueh-Li Tan, Zaid Haddad, Jessica Hicks, Nilesh Gupta, Jonathan I. Epstein, George J. Netto, William B. Isaacs, Jun Luo, Rohit Mehra, Robert L. Vessella, R. Jeffrey Karnes, Edward M. Schaeffer, Elai Davicioni, Angelo M. De Marzo, Tamara L. Lotan
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (24): 5619–5629.
https://doi.org/10.1158/1078-0432.CCR-15-0744
Published: 14 December 2015
View article titled, Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas
Open the PDF for Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas in another window
Includes: Supplementary data
Journal Articles

SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer

Xiaotun Zhang, Ilsa M. Coleman, Lisha G. Brown, Lawrence D. True, Lori Kollath, Jared M. Lucas, Hung-Ming Lam, Ruth Dumpit, Eva Corey, Lisly Chéry, Bryce Lakely, Celestia S. Higano, Bruce Montgomery, Martine Roudier, Paul H. Lange, Peter S. Nelson, Robert L. Vessella, Colm Morrissey
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (20): 4698–4708.
https://doi.org/10.1158/1078-0432.CCR-15-0157
Published: 14 October 2015
View article titled, SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer
Open the PDF for SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Serum Glutamate Levels Correlate with Gleason Score and Glutamate Blockade Decreases Proliferation, Migration, and Invasion and Induces Apoptosis in Prostate Cancer Cells

Shahriar Koochekpour, Sunipa Majumdar, Gissou Azabdaftari, Kristopher Attwood, Ray Scioneaux, Dhatchayini Subramani, Charles Manhardt, Giovanni D. Lorusso, Stacey S. Willard, Hillary Thompson, Mojgan Shourideh, Katayoon Rezaei, Oliver Sartor, James L. Mohler, Robert L. Vessella
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (21): 5888–5901.
https://doi.org/10.1158/1078-0432.CCR-12-1308
Published: 06 November 2012
View article titled, Serum Glutamate Levels Correlate with Gleason Score and Glutamate Blockade Decreases Proliferation, Migration, and Invasion and Induces Apoptosis in Prostate Cancer Cells
Open the PDF for Serum Glutamate Levels Correlate with Gleason Score and Glutamate Blockade Decreases Proliferation, Migration, and Invasion and Induces Apoptosis in Prostate Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Human Prostate Cancer in a Clinically Relevant Xenograft Mouse Model: Identification of β(1,6)-Branched Oligosaccharides as a Marker of Tumor Progression

Tobias Lange, Sebastian Ullrich, Imke Müller, Michael F. Nentwich, Katrin Stübke, Susanne Feldhaus, Christine Knies, Olaf J.C. Hellwinkel, Robert L. Vessella, Claudia Abramjuk, Mario Anders, Jennifer Schröder-Schwarz, Thorsten Schlomm, Hartwig Huland, Guido Sauter, Udo Schumacher
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (5): 1364–1373.
https://doi.org/10.1158/1078-0432.CCR-11-2900
Published: 01 March 2012
View article titled, Human Prostate Cancer in a Clinically Relevant Xenograft Mouse Model: Identification of β(1,6)-Branched Oligosaccharides as a Marker of Tumor Progression
Open the PDF for Human Prostate Cancer in a Clinically Relevant Xenograft Mouse Model: Identification of β(1,6)-Branched Oligosaccharides as a Marker of Tumor Progression in another window
Journal Articles

Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants

Elahe A. Mostaghel, Brett T. Marck, Stephen R. Plymate, Robert L. Vessella, Stephen Balk, Alvin M. Matsumoto, Peter S. Nelson, R. Bruce Montgomery
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (18): 5913–5925.
https://doi.org/10.1158/1078-0432.CCR-11-0728
Published: 14 September 2011
View article titled, Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants
Open the PDF for Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants in another window
Includes: Supplementary data
Journal Articles

Human Prostate Cancer Harbors the Stem Cell Properties of Bone Marrow Mesenchymal Stem Cells

Haiyen E. Zhau, Hui He, Christopher Y. Wang, Majd Zayzafoon, Colm Morrissey, Robert L. Vessella, Fray F. Marshall, Leland W. K. Chung, Ruoxiang Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (8): 2159–2169.
https://doi.org/10.1158/1078-0432.CCR-10-2523
Published: 14 April 2011
View article titled, Human Prostate Cancer Harbors the Stem Cell Properties of Bone Marrow Mesenchymal Stem Cells
Open the PDF for Human Prostate Cancer Harbors the Stem Cell Properties of Bone Marrow Mesenchymal Stem Cells in another window
Journal Articles

Transforming Growth Factor-β–Stimulated Clone-22 Is an Androgen-Regulated Gene That Enhances Apoptosis in Prostate Cancer following Insulin-Like Growth Factor-I Receptor Inhibition

Cynthia C.T. Sprenger, Kathleen Haugk, Shihua Sun, Ilsa Coleman, Peter S. Nelson, Robert L. Vessella, Dale L. Ludwig, Jennifer D. Wu, Stephen R. Plymate
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (24): 7634–7641.
https://doi.org/10.1158/1078-0432.CCR-09-0264
Published: 14 December 2009
View article titled, Transforming Growth Factor-β–Stimulated Clone-22 Is an Androgen-Regulated Gene That Enhances Apoptosis in Prostate Cancer following Insulin-Like Growth Factor-I Receptor Inhibition
Open the PDF for Transforming Growth Factor-β–Stimulated Clone-22 Is an Androgen-Regulated Gene That Enhances Apoptosis in Prostate Cancer following Insulin-Like Growth Factor-I Receptor Inhibition in another window
Journal Articles

Disseminated Tumor Cells in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease Predicts Biochemical Recurrence

Todd M. Morgan, Paul H. Lange, Michael P. Porter, Daniel W. Lin, William J. Ellis, Ian S. Gallaher, Robert L. Vessella
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (2): 677–683.
https://doi.org/10.1158/1078-0432.CCR-08-1754
Published: 15 January 2009
View article titled, Disseminated Tumor Cells in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease Predicts Biochemical Recurrence
Open the PDF for Disseminated Tumor Cells in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease Predicts Biochemical Recurrence in another window
Journal Articles

Advancing Treatment for Metastatic Bone Cancer: Consensus Recommendations from the Second Cambridge Conference

Robert E. Coleman, Theresa A. Guise, Allan Lipton, G. David Roodman, James R. Berenson, Jean-Jacques Body, Brendan F. Boyce, Laura M. Calvi, Peyman Hadji, Eugene V. McCloskey, Fred Saad, Matthew R. Smith, Larry J. Suva, Russell S. Taichman, Robert L. Vessella, Katherine N. Weilbaecher
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (20): 6387–6395.
https://doi.org/10.1158/1078-0432.CCR-08-1572
Published: 16 October 2008
View article titled, Advancing Treatment for Metastatic Bone Cancer: Consensus Recommendations from the Second Cambridge Conference
Open the PDF for Advancing Treatment for Metastatic Bone Cancer: Consensus Recommendations from the Second Cambridge Conference in another window
Journal Articles

TMPRSS2:ERG Fusion Identifies a Subgroup of Prostate Cancers with a Favorable Prognosis

Outi R. Saramäki, Anna E. Harjula, Paula M. Martikainen, Robert L. Vessella, Teuvo L.J. Tammela, Tapio Visakorpi
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (11): 3395–3400.
https://doi.org/10.1158/1078-0432.CCR-07-2051
Published: 02 June 2008
View article titled, <em>TMPRSS2</em>:<em>ERG</em> Fusion Identifies a Subgroup of Prostate Cancers with a Favorable Prognosis
Open the PDF for <em>TMPRSS2</em>:<em>ERG</em> Fusion Identifies a Subgroup of Prostate Cancers with a Favorable Prognosis in another window
Journal Articles

Advances in Treating Metastatic Bone Cancer: Summary Statement for the First Cambridge Conference

Allan Lipton, James R. Berenson, Jean-Jacques Body, Brendan F. Boyce, Oyvind S. Bruland, Michael A. Carducci, Charles S. Cleeland, Denis R. Clohisy, Robert E. Coleman, Richard J. Cook, Theresa A. Guise, Roger N. Pearse, Trevor J. Powles, Michael J. Rogers, G. David Roodman, Matthew R. Smith, Larry J. Suva, Robert L. Vessella, Katherine N. Weilbaecher, Laura King
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (20): 6209s–6212s.
https://doi.org/10.1158/1078-0432.CCR-06-1213
Published: 24 October 2006
View article titled, Advances in Treating Metastatic Bone Cancer: Summary Statement for the First Cambridge Conference
Open the PDF for Advances in Treating Metastatic Bone Cancer: Summary Statement for the First Cambridge Conference in another window
Journal Articles

Targeting Factors Involved in Bone Remodeling as Treatment Strategies in Prostate Cancer Bone Metastasis

Robert L. Vessella, Eva Corey
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (20): 6285s–6290s.
https://doi.org/10.1158/1078-0432.CCR-06-0813
Published: 24 October 2006
View article titled, Targeting Factors Involved in Bone Remodeling as Treatment Strategies in Prostate Cancer Bone Metastasis
Open the PDF for Targeting Factors Involved in Bone Remodeling as Treatment Strategies in Prostate Cancer Bone Metastasis in another window
Journal Articles

Prostate Stem Cell Antigen Is Overexpressed in Prostate Cancer Metastases

John S. Lam, Joyce Yamashiro, I. Peter Shintaku, Robert L. Vessella, Robert B. Jenkins, Steve Horvath, Jonathan W. Said, Robert E. Reiter
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (7): 2591–2596.
https://doi.org/10.1158/1078-0432.CCR-04-1842
Published: 06 April 2005
View article titled, Prostate Stem Cell Antigen Is Overexpressed in Prostate Cancer Metastases
Open the PDF for Prostate Stem Cell Antigen Is Overexpressed in Prostate Cancer Metastases in another window
Journal Articles

Expression of Androgen Receptor Coregulators in Prostate Cancer

Marika J. Linja, Kati P. Porkka, Zhikang Kang, Kimmo J. Savinainen, Olli A. Jänne, Teuvo L. J. Tammela, Robert L. Vessella, Jorma J. Palvimo, Tapio Visakorpi
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (3): 1032–1040.
https://doi.org/10.1158/1078-0432.CCR-0990-3
Published: 10 February 2004
View article titled, Expression of Androgen Receptor Coregulators in Prostate Cancer
Open the PDF for Expression of Androgen Receptor Coregulators in Prostate Cancer in another window
Journal Articles

Zoledronic Acid Exhibits Inhibitory Effects on Osteoblastic and Osteolytic Metastases of Prostate Cancer

Eva Corey, Lisha G. Brown, Janna E. Quinn, Martin Poot, Martine P. Roudier, Celestia S. Higano, Robert L. Vessella
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (1): 295–306.
Published: 01 January 2003
View article titled, Zoledronic Acid Exhibits Inhibitory Effects on Osteoblastic and Osteolytic Metastases of Prostate Cancer
Open the PDF for Zoledronic Acid Exhibits Inhibitory Effects on Osteoblastic and Osteolytic Metastases of Prostate Cancer in another window
Journal Articles

Inhibition of Androgen-independent Growth of Prostate Cancer Xenografts by 17β-Estradiol

Eva Corey, Janna E. Quinn, Mary J. Emond, Kent R. Buhler, Lisha G. Brown, Robert L. Vessella
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (4): 1003–1007.
Published: 01 April 2002
View article titled, Inhibition of Androgen-independent Growth of Prostate Cancer Xenografts by 17β-Estradiol
Open the PDF for Inhibition of Androgen-independent Growth of Prostate Cancer Xenografts by 17β-Estradiol in another window
Journal Articles

Serum Osteoprotegerin Levels Are Increased in Patients with Advanced Prostate Cancer

Julie M. Brown, Robert L. Vessella, Paul J. Kostenuik, Colin R. Dunstan, Paul H. Lange, Eva Corey
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (10): 2977–2983.
Published: 01 October 2001
View article titled, Serum Osteoprotegerin Levels Are Increased in Patients with Advanced Prostate Cancer
Open the PDF for Serum Osteoprotegerin Levels Are Increased in Patients with Advanced Prostate Cancer in another window